Search Results 1461-1470 of 28603 for oral

1. A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients - Mayo Clinic

   Clinical Trials · A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients · More about research at Mayo ...

2. A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

   A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant. Print details.

3. The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

   The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) ...

4. Ombitasvir, paritaprevir, ritonavir and dasabuvir (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For chronic hepatitis C virus infection, with or without ribavirin: Adults—2 pink tablets once a day (taken in the morning) ...

5. Athlete's foot - Diagnosis and treatment - Mayo Clinic

   Or you might need both topical and oral medicine. Request an appointment. There is a problem with information submitted for this request. Review/update the ...

6. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin ...

7. Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies - Mayo Clinic

   The purpose of this study is to demonstrate the effectiveness of neflamapimod, compared to placebo, as a treatment for DLB, as assessed by the Clinical Dementia ...

8. 14c urea (oral route) - Side effects & dosage - Mayo Clinic

   14c urea (oral route) · Brand Name. US Brand Name. Pytest · Description This product is available in the following dosage forms: Capsule · Before Using Other ...

9. Captopril and hydrochlorothiazide (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For high blood pressure: Adults—At first, one tablet once a day. Your doctor may adjust your dose as needed. However, the ...

10. Empagliflozin, linagliptin, and metformin (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage form (extended-release tablets):. For type 2 diabetes: Adults—1 tablet of 10 milligrams (mg) empagliflozin, 5 mg linagliptin, and 1000 mg ...